4//SEC Filing
Kern Ralph Dr. 4
Accession 0001144204-18-015580
CIK 0001137883other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 4:05 PM ET
Size
5.4 KB
Accession
0001144204-18-015580
Insider Transaction Report
Form 4
Kern Ralph Dr.
COO and Chief Medical Officer
Transactions
- Award
Common Stock
2018-03-15$3.60/sh+5,000$17,997→ 40,885 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.59 to $3.60, inclusive. The reporting person undertakes to provide to Brainstorm Cell Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
BRAINSTORM CELL THERAPEUTICS INC.
CIK 0001137883
Entity typeother
Related Parties
1- filerCIK 0001699684
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 4:05 PM ET
- Size
- 5.4 KB